HOME WORLD INDIA BHOPAL BUSINESS ENTERTAINMENT SCIENCE & TECHNOLOGY SPORTS HEALTH
WTN SPECIAL GOSSIP CORNER RECIPES DRINKS FUN FACTS WTN HINDI
EDUCATION LIFESTYLE TRAVEL ART & LITERATURE BIG MEMSAAB OPINION & INTERVIEW BrahMos
ABOUT US PRIVACY POLICY SITEMAP CONTACT US
BREAKING NEWS
Top seeds Siniakova, Zhang lift the women's doubles title in Toronto
Amitabh Bachchan recalls Dharmendra’s large-heartedness, says his house was ‘free for all’
India building domestic capabilities from chip design to indigenous AI models
Born to parents who bore the brunt, scars: Hardeep Singh Puri on Partition Horrors Remembrance Day
Sharad Kelkar says he felt immense sense of pride while donning Indian military officer’s uniform ahead of 80th Independence Day
Niharika Chouksey calls 400 episodes of ‘Tumm Se Tumm Tak’, a testament to the bond of show’s lead pair
Home / Health

DCGI grants EUA to 3 Covid vaccines for different age group of children (ld)

26 Apr 2022
Health
DCGI grants EUA to 3 Covid vaccines for different age group of children (ld)
New Delhi, April 26 (IANS) The Drugs Controller General of India (DCGI) on Tuesday approved three Covid vaccines for the restricted emergency use authorisation (EUA) for children of different age groups.
The DCGI gave the restricted emergency use authorisation to Bharat Biotech's Covaxin for children between the age of 6-12 years.
In another development, the drug regulator approved restricted use in emergency situation for Biological E's Covid-19 vaccine Corbevax for children of 5 to 12 years age group.
Besides Corbevax and Covaxin, the DCGI also approved restricted use iA emergency situation to ZycovD (Zydus Cadila vaccine) for children above the age of 12 years for a two-dose regimen.
"India's fight against Covid more stronger!
@CDSCO_INDIA_INF has approved Covaxin for 6 to 12 years of age group, Corbevax for 5 to 12 years age group of children and two doses ZyCoV-D for above 12 years of age group for Restricted Use in Emergency Situations," Union Health Minister Mansukh Mandaviya tweeted in Hindi.
This development comes after the Subject Expert Committee discussed recommendations for the restricted emergency use of Covaxin in children aged between 2-12 years.
However, the SEC, after a meeting on Thursday, has recommended restricted emergency use of Biological E's Covid-19 vaccine, Corbevax, in children aged 5-12 years.

--IANS avr/svn/

(Disclaimer: This post has been auto published from IANS news agency without any modification to the text and has not been reviewed by editor)